Converting a Commercial Fed-Batch Process to Continuous Manufacturing

Authors

Andrea Squeri, Bioprocess Technologies & Engineering, Biopharmaceutical Development, R&D, AstraZeneca Gaithersburg, USFollow
Robert Luo, Cell Culture & Fermentation Sciences, Biopharmaceutical Development, R&D, AstraZeneca Gaithersburg, US
Ken Lee, Bioprocess Technologies & Engineering, Biopharmaceutical Development, R&D, AstraZeneca Gaithersburg, US
Jon Coffman, Bioprocess Technologies & Engineering, R&D, Biopharmaceutical Development, AstraZeneca Gaithersburg, US

Conference Dates

October 20 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Andrea Squeri, Robert Luo, Ken Lee, and Jon Coffman, "Converting a Commercial Fed-Batch Process to Continuous Manufacturing" in "Integrated Continuous Biomanufacturing VI", Ana Azevedo, Instituto Superior Técnico, Portugal; Aaron Noyes, Apogee Therapeutics, USA; Kevin Brower, Sanofi, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/biomanufact_vi/83